Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Cutaneous vasculitis
ADR ID BADD_A01133
ADR Hierarchy
10      Immune system disorders
10.02      Immune disorders NEC
10.02.02      Vasculitides
10.02.02.003      Cutaneous vasculitis
23      Skin and subcutaneous tissue disorders
23.06      Skin vascular abnormalities
23.06.02      Skin vasculitides
23.06.02.001      Cutaneous vasculitis
24      Vascular disorders
24.12      Vascular infections and inflammations
24.12.04      Vasculitides NEC
24.12.04.008      Cutaneous vasculitis
Description Not Available
MedDRA Code 10011686
MeSH ID Not Available
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Cutaneous vasculitis | Leucocytoclastic vasculitis | Leukocytoclastic vasculitis | Skin vasculitis NOS | Cutaneous small vessel vasculitis
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00653Diclofenac0.000064%
BADD_D00696Divalproex sodium--
BADD_D00772Enoxaparin sodium--
BADD_D00800Erlotinib0.000168%
BADD_D00838Etanercept--
BADD_D00850Etodolac--
BADD_D00869Famotidine0.000045%
BADD_D00873Fenofibrate0.000039%
BADD_D00897Filgrastim--
BADD_D00912Fluconazole0.000045%
BADD_D00919Flumazenil--
BADD_D00931Fluorouracil0.000276%
BADD_D00981Gabapentin0.000047%
BADD_D01008Gefitinib--
BADD_D01035Golimumab--
BADD_D01081Hydralazine0.000423%
BADD_D01083Hydrochlorothiazide--
BADD_D01093Hydroflumethiazide--
BADD_D01110Hydroxyurea0.000112%
BADD_D01119Ibrutinib0.000280%
BADD_D01157Infliximab--
BADD_D01194Irbesartan--
BADD_D01217Itraconazole0.002672%
BADD_D01243Lamotrigine0.000166%
BADD_D01252Leflunomide--
BADD_D01253Lenalidomide--
BADD_D01257Letrozole0.000527%
BADD_D01265Levetiracetam0.000397%
BADD_D01275Levofloxacin0.000148%
BADD_D01295Linezolid0.002470%
The 2th Page    First    Pre   2 3 4    Next   Last    Total 4 Pages